Protective effect of BNT162b2 vaccination on aerobic capacity following mild to moderate SARS-CoV-2 infection: a cross sectional study, Israel, March-December 2021

Yair Blumberg, Michael Edelstein, Kamal Abu Jabal, Ron Golan, Yuval Perets, Musa Saad, Tatyana Levinas, Saleem Dabbah, Zeev Israeli, Salah Yacoubi, Alaa Abu Raya, Anat Amital, Majdi Halabi
doi: https://doi.org/10.1101/2021.12.30.21268538

Article usage

Article usage: January 2022 to August 2025

AbstractFullPdf
Jan 2022221133439
Feb 20221583835
Mar 2022175515
Apr 2022145125
May 2022110018
Jun 2022122222
Jul 202268911
Aug 20227149
Sep 202299313
Oct 202258214
Nov 202251114
Dec 20223603
Jan 20233206
Feb 20234936
Mar 20233332
Apr 202327110
May 20232337
Jun 20231343
Jul 20231113
Aug 202322117
Sep 202315420
Oct 202333211
Nov 20231970
Dec 20231524
Jan 2024873
Feb 20241456
Mar 20242088
Apr 202417810
May 2024923
Jun 20242094
Jul 20241148
Aug 2024281512
Sep 20242768
Oct 20241770
Nov 20241548
Dec 2024747
Jan 20253335
Feb 202514194
Mar 2025283310
Apr 202520312
May 2025191316
Jun 2025551317
Jul 2025241914
Aug 2025205
Back to top
Posted January 02, 2022.
Download PDF
Data/Code
Email
Protective effect of BNT162b2 vaccination on aerobic capacity following mild to moderate SARS-CoV-2 infection: a cross sectional study, Israel, March-December 2021
Yair Blumberg, Michael Edelstein, Kamal Abu Jabal, Ron Golan, Yuval Perets, Musa Saad, Tatyana Levinas, Saleem Dabbah, Zeev Israeli, Salah Yacoubi, Alaa Abu Raya, Anat Amital, Majdi Halabi
medRxiv 2021.12.30.21268538; doi: https://doi.org/10.1101/2021.12.30.21268538
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area